Início Biotecnologia AryoGen Pharmed
A

AryoGen Pharmed

Perfil gerido pelo Bizz Id
Irão 201-500 2010

Descrição

A AryoGen Pharmed é uma empresa biofarmacêutica iraniana do grupo CinnaGen que produz biossimilares: anticorpos monoclonais, proteínas de fusão e fatores de coagulação recombinantes. Segundo o seu site, exporta para 29 países.

Produtos

12 produtos
Bevacizumab

Brand: Stivant. Bevacizumab biosimilar. Metastatic colorectal cancer, progressive glioblastoma, NSCLC, advanced or metastatic kidney cancer, epithelial ovarian, fallopian tube and primary peritoneal cancer, cervical cancer and metastatic breast cancer.

Produto acabado

Verificado a 2026-10-21

Bevacizumab: see suppliers →

Denosumab (Artenix)

Brand: Artenix. Monoclonal IgG2 antibody binding RANKL. Indication not stated on the website.

Produto acabado

Verificado a 2026-10-21

Denosumab: see suppliers →

Denosumab (Arylia)

Brand: Arylia. Human IgG2 monoclonal antibody binding RANKL. Osteoporosis (the website describes postmenopausal, male and treatment-related osteoporosis).

Produto acabado

Verificado a 2026-10-21

Denosumab: see suppliers →

Dupilumab

Brand: Aryxent. Monoclonal antibody blocking IL-4 and IL-13. Atopic dermatitis, asthma, eosinophilic esophagitis, chronic spontaneous urticaria, prurigo nodularis and COPD. Aryxent 200 and Aryxent 300 presentations.

Produto acabado

Verificado a 2026-10-21

Dupilumab: see suppliers →

Efmoroctocog alfa

Brand: Coageight. Recombinant coagulation factor VIII, Fc fusion protein, produced in CHO cells. Treatment and prevention of bleeding in haemophilia A, all age groups.

Produto acabado

Verificado a 2026-10-21

Efmoroctocog alfa: see suppliers →

Etanercept

Brand: Altebrel. Etanercept biosimilar, TNF-blocking fusion protein produced in CHO cells. Rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, juvenile idiopathic arthritis, enthesitis-related arthritis and plaque psoriasis. Prefilled syringes 25 mg and 50 mg.

Produto acabado

Verificado a 2026-10-21

Etanercept: see suppliers →

Infliximab

Brand: Rheuflix. Contains infliximab; chronic inflammatory diseases, particularly rheumatoid arthritis.

Produto acabado

Verificado a 2026-10-21

Infliximab: see suppliers →

Recombinant activated human blood coagulation factor VIIa (rFVIIa)

Brand: AryoSeven. Glycoprotein produced in BHK cells by recombinant technology. Control, treatment and prevention of bleeding in congenital haemophilia A or B with inhibitors, acquired haemophilia, congenital factor VII deficiency and Glanzmann's thrombasthenia. Marketed as 1.2 mg (60 KIU), 2.4 mg (120 KIU) and 4.8 mg (240 KIU) lyophilised powder for injection.

Comercializado (mercado no indicado)

Registo submetido

Produto acabado

Verificado a 2026-10-21

Rituximab

Brand: Zytux. Rituximab biosimilar, chimeric monoclonal antibody produced in CHO cells. Non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, GPA and MPA, pemphigus vulgaris. 100 mg and 500 mg vials for infusion.

Produto acabado

Verificado a 2026-10-21

Rituximab: see suppliers →

Tocilizumab

Brand: Temziva. Contains tocilizumab (IL-6 blocker). Cytokine release syndrome (CRS) in adults and children aged 2 and older with confirmed COVID-19. 400 mg/20 mL vial.

Aprobado «Food and Drug Administration» (país no indicado)

Registo submetido

Produto acabado

Verificado a 2026-10-21

Tocilizumab: see suppliers →

Trastuzumab

Brand: AryoTrust. Trastuzumab biosimilar produced in recombinant CHO cells. HER2-overexpressing early and metastatic breast cancer and metastatic gastric cancer. Lyophilised powder for infusion, 150 mg and 440 mg.

Produto acabado

Verificado a 2026-10-21

Trastuzumab: see suppliers →

Vedolizumab

Brand: VedAryo. Humanized IgG1 monoclonal antibody binding integrin α4β7, produced in CHO cells.

Produto acabado

Verificado a 2026-10-21

Vedolizumab: see suppliers →

Contactar empresa

Registe-se gratuitamente para ver os dados de contacto desta empresa e escrever-lhe.

Registar - Gratuito